21 Nov Year in Review: Alzheimer’s Disease
Diagnostic blood tests were approved, and the number of Americans with Alzheimer's kept climbing...
Diagnostic blood tests were approved, and the number of Americans with Alzheimer's kept climbing...
Steps have been made towards clinical trial equity, but framework consistency is needed to facilitate further improvements....
Hundreds of clinical trials and tens of thousands of participants were affected by NIH grant terminations earlier this year, a cross-sectional study indicated....
Understanding gender and sex differences – and ultimately preventing Alzheimer’s disease and related dementia – is at the root of the pioneering work of Jessica Caldwell, PhD, a new faculty member in the University of Wisconsin–Madison Alzheimer’s disease programs....
A new research center at the University of Wisconsin School of Medicine and Public Health will focus on understanding how metabolic changes associated with aging influence health and cause disease....
Diabetes is a growing epidemic in Wisconsin. Its rise has been linked to limited access to healthy food and health care in some communities, lower levels of physical activity, and a rise in obesity, among other factors....
As the Wisconsin Alumni Research Foundation commemorates its 100th anniversary, the foundation today announced a historic investment in the future of research and innovation at the University of Wisconsin-Madison....
Promising results from a new malaria drug, ganaplacide–lumefantrine, offer hope against emerging drug resistance in Africa....
A new agreement between the University of Wisconsin School of Medicine and Public Health and NorthStar Medical Radioisotopes, LLC (NorthStar) is aimed at advancing research and supporting workforce development in the nuclear medicine sector....
A five-year, $12.5 million grant has been awarded to researchers at UW–Madison to investigate metastatic, or advanced stage, prostate cancer, the second most common cause of cancer death in men....